The Boston Scientific Coyote Balloon Catheter (REF H74939185351290) is a low-profile, over-the-wire percutaneous transluminal angioplasty (PTA) balloon catheter featuring a 3.5 mm balloon diameter and 120 mm balloon length. Engineered for navigation through tortuous peripheral anatomy, the Coyote platform combines a flexible distal segment with a supportive proximal shaft to facilitate lesion access and balloon delivery in distal vascular beds.
Key Features
Low-profile balloon design intended to support crossing of tight or distal lesions.
Over-the-wire configuration compatible with a 0.014 inch guidewire.
Balloon dimensions: 3.5 mm nominal diameter x 120 mm working length.
Tapered, flexible distal tip designed to aid trackability through tortuous vessels.
Two radiopaque marker bands for fluoroscopic balloon positioning.
Hydrophilic coating on the distal shaft to support deliverability.
Rated burst pressure and nominal pressure: Not specified in the located sources.
Clinical Applications
Indicated by the manufacturer for percutaneous transluminal angioplasty in the peripheral vasculature; refer to the official Instructions for Use (IFU) for the complete list of approved indications, contraindications, warnings, and precautions.
Commonly used by clinicians for balloon dilatation in below-the-knee (BTK), tibial, peroneal, and other small-vessel peripheral interventions.
May be used to predilate lesions prior to additional endovascular therapy as determined by the treating physician.
Product Information
Brand: Boston Scientific
Product Line: Coyote Balloon Catheter
Category: Peripheral Balloon Catheters
Balloon Diameter: 3.5 mm
Balloon Length: 120 mm
Catheter Type: Over-the-wire PTA balloon catheter
Guidewire Compatibility: 0.014 inch
Usable Catheter Length: Not specified in the located sources
Introducer Sheath Compatibility: Not specified in the located sources
REF / UPN: H74939185351290
Sterility: Sterile, single-use device (refer to product labeling)
Packaging: Not specified in the located sources
Regulatory status, clinical suitability, and patient selection should be confirmed against the official manufacturer IFU and applicable local regulations.